Hematological alterations and thymic function in newborns of HIV-infected mothers receiving antiretroviral drugs

Indian Pediatrics

Volumn 50, Issue 6, 2013, Pages 567-572

  Wongnoi, Rotjanee ^a   Penvieng, Nawaporn ^a   Singboottra, Panthong ^a   Kingkeow, Doungnapa ^a   Oberdorfer, Peninnah ^a   Sirivatanapa, Pannee ^b   Pornprasert, Sakorn ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Adverse effects; Antiretroviral drugs; Hematology; HIV; Newborn; Thymic function

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN; LAMIVUDINE; LOPINAVIR; RITONAVIR; T LYMPHOCYTE RECEPTOR; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD HEALTH; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HEMATOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NEUTROPHIL COUNT; NEWBORN; REAL TIME POLYMERASE CHAIN REACTION; THAILAND; THROMBOCYTE COUNT; THYMUS FUNCTION; UMBILICAL CORD BLOOD; BLOOD; COHORT ANALYSIS; HIV INFECTIONS; METABOLISM; MOTHER; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T LYMPHOCYTE; VIROLOGY;

ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MALE; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T-LYMPHOCYTES;

EID: 84880027704     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-013-0169-y     Document Type: Article

References (28)

1. Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005;308:1582-1583.
2. Burns DN, Mofenson LM. Paediatric HIV-1 infection. Lancet. 1999;354:SII1-6.
3. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-465.
4. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484-494.
5. Baroncelli S, Pinnetti C, Genovese O, Tamburrini E, Floridia M. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine. J Med Virol. 2011;83:551-556.
6. El Beitune P, Duarte G. Antiretroviral agents during pregnancy: consequences on hematologic parameters in HIV-exposed, uninfected newborn infant. Eur J Obstet Gynecol Reprod Biol. 2006;128:59-63.
7. Feiterna-Sperling C, Weizsaecker K, Buhrer C, Casteleyn S, Loui A, Schmitz T, et al. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants. J Acquir Immune Defic Syndr. 2007;45:43-51.
8. Gribaldo L, Malerba I, Collotta A, Casati S, Pessina A. Inhibition of CFU-E/BFU-E by 3′-azido-3′-deoxythymidine, chlorpropamide, and protoporphirin IX zinc (II): a comparison between direct exposure of progenitor cells and long-term exposure of bone marrow cultures. Toxicol Sci. 2000;58:96-101.
9. Pinnetti C, Baroncelli S, Molinari A, Nardini G, Genovese O, Ricerca BM, et al. Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. J Infect. 2011;63:144-150.
10. Moyle G, Sawyer W, Law M, Amin J, Hill A. Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies. Clin Ther. 2004;26:92-97.
11. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS. 2003;17:2053-2061.
12. Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, Foca M, et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. J Infect Dis. 2006;194:1089-1097.
13. Watson WJ, Stevens TP, Weinberg GA. Profound anemia in a newborn infant of a mother receiving antiretroviral therapy. Pediatr Infect Dis J. 1998;17:435-436.
14. Bains I, Thiebaut R, Yates AJ, Callard R. Quantifying thymic export: combining models of naive T cell proliferation and TCR excision circle dynamics gives an explicit measure of thymic output. J Immunol. 2009;183:4329-4336.
15. Steinmann GG, Klaus B, Muller-Hermelink HK. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol. 1985;22:563-575.
16. Livak F, Schatz DG. T-cell receptor alpha locus V(D)J recombination by-products are abundant in thymocytes and mature T cells. Mol Cell Biol. 1996;16:609-618.
17. Clark DR, Repping S, Pakker NG, Prins JM, Notermans DW, Wit FW, et al. T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy. Blood. 2000;96:242-249.
18. Dam Nielsen S, Kjaer Ersboll A, Mathiesen L, Nielsen JO, Hansen JE. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients. J Infect Dis. 1998;178:1299-1305.
19. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sorensen TU, Dreves AM, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood. 2001;98:398-404.
20. Winichagoon P. Prevention and control of anemia: Thailand experiences. J Nutr. 2002;132:862-866.
21. Ometto L, De Forni D, Patiri F, Trouplin V, Mammano F, Giacomet V, et al. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness. AIDS. 2002;16:839-849.
22. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood. 2000;96:3866-3871.
23. Eyer-Silva WA, Arabe J, Pinto JF, Morais-De-Sa CA. Macrocytosis in patients on stavudine. Scand J Infect Dis 2001;33:239-240.
24. Kolte L, Ryder LP, Albrecht-Beste E, Jensen FK, Nielsen SD. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy. Scand J Immunol. 2009;70:608-613.
25. Bunders M, Thorne C, Newell ML. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS. 2005;19:1071-1079.
26. Rodriguez EM, Mofenson LM, Chang BH, Rich KC, Fowler MG, Smeriglio V, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS. 1996;10:273-282.
27. Bunders MJ, Bekker V, Scherpbier HJ, Boer K, Godfried M, Kuijpers TW. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr. 2005;94:1571-1577.
28. Tanphaichitr VS, Mahasandana C, Suvatte V, Yodthong S, Pung-amritt P, Seeloem J. Prevalence of hemoglobin E, alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency in 1,000 cord bloods studied in Bangkok. Southeast Asian J Trop Med Public Health. 1995;26:271-274.